Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study
Authors:
Open Access
Abstract
Background: Epigenetic alterations accumulate in normal-appearing tissues of patients with cancer, producing an epigenetic field defect. Cross-sectional studies show that the degree of the defect may be associated with risk in some types of cancer, especially cancers associated with chronic inflammation. Objective: To demonstrate, by a multicentre prospective cohort study, that the risk of metachronous gastric cancer after endoscopic resection (ER) can be predicted by assessment of the epigenetic field defect using methylation levels. Design: Patients with early gastric cancer, aged 40–80 years, who planned to have, or had undergone, ER, were enrolled at least 6 months after Helicobacter pylori infection discontinued. Methylation levels of three preselected genes ( miR-124a-3 , EMX1 and NKX6-1 ) were measured by quantitative methylation-specific PCR. Patients were followed up annually by endoscopy, and the primary endpoint was defined as detection of a metachronous gastric cancer. Authentic metachronous gastric cancers were defined as cancers excluding those detected within 1 year after the enrolment. Results: Among 826 patients enrolled, 782 patients had at least one follow-up, with a median follow-up of 2.97 years. Authentic metachronous gastric cancers developed in 66 patients: 29, 16 and 21 patients at 1–2, 2–3 and ≥3 years after the enrolment, respectively. The highest quartile of the miR-124a-3 methylation level had a significant univariate HR (95% CI) (2.17 (1.07 to 4.41); p=0.032) and a multivariate-adjusted HR (2.30 (1.03 to 5.10); p=0.042) of developing authentic metachronous gastric cancers. Similar trends were seen for EMX1 and NKX6-1 . Conclusions: Assessment of the degree of an epigenetic field defect is a promising cancer risk marker that takes account of life history.Keywords
This publication has 38 references indexed in Scilit:
- Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancerGastrointestinal Endoscopy, 2012
- Revisit of Field Cancerization in Squamous Cell Carcinoma of Upper Aerodigestive Tract: Better Risk Assessment with Epigenetic MarkersCancer Prevention Research, 2011
- Eradication of H. pylori Did Not Improve Abnormal Sonic Hedgehog Expression in the High Risk Group for Gastric CancerDigestive Diseases and Sciences, 2011
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- Prediction of the risk for gastric cancer using candidate methylation markers in the non‐neoplastic gastric mucosaeThe Journal of Pathology, 2011
- A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's EsophagusCancer Research, 2009
- Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trialThe Lancet, 2008
- Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinomaHepatology, 2008
- Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance?Gastric Cancer, 2006
- Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylationGut, 2006